Does NMN help blood sugar? (Grade — evidence)
NMN may modestly help blood sugar in specific populations (Grade C, low certainty), especially in middle-age/older adults, mainly non-diabetic. Dose range: 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials.
Bottom line. NMN may modestly help blood sugar in specific populations (Grade C, low certainty), especially in middle-age/older adults, mainly non-diabetic. Dose range: 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials. [1 RCT]
- Direction
- null
- Magnitude
- Review of 8 human RCTs (342 mainly non-diabetic middle-age/older adults, 14 days to 12 weeks, 250-2000 mg/day): NMN supplementation showed no significant benefit on fasting glucose, fasting insulin, HbA1c, insulin resistance (HOMA-IR), or lipid profile. Short-term NMN supplementation did not meaningfully improve glucose control in this population.
- Grade
- —
- Certainty
- low
- Clinical meaning
- no established threshold
- Who it applies to
- middle-age/older adults, mainly non-diabetic
- Dose / form studied
- Safety
- none identified in this claim
- The one limitation
- Sample sizes are small in most included trials; effect sizes may shrink with larger studies.
Reviewed · Evidence last changed · Claim clm_ec_b11-nmn-blood-sugar v1
Grade or certainty not assigned — evidence bucket does not yet warrant a graded claim.
Who it works for
Best-studied in middle-age/older adults, mainly non-diabetic. Effective doses cluster around 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials.
Evidence
| Study | Design | Cite |
|---|---|---|
| Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. | peer-reviewed | PMID:39531138 |
Why this grade
Reasoning trace
Grade — at low certainty. The grade reflects the direction and size of the effect across the 1 publishable source above; certainty reflects heterogeneity, sample sizes, and design quality. What would move it upward: additional well-powered RCTs in the target population that replicate the effect at similar doses. What would move it down: a large null trial, discovery of publication bias, or a retraction of a keystone study.
Dose & form
Studied intake: 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials.
How it stacks up for blood sugar
- NMN vs Berberine for blood sugar — Berberine Grade B
- NMN vs Magnesium for blood sugar — Magnesium Grade C
- NMN vs Myo-Inositol for blood sugar — Myo-Inositol Grade B
- NMN vs Ashwagandha for blood sugar — Ashwagandha Grade C
- NMN vs Omega-3 for blood sugar — Omega-3 Grade B
- NMN vs Creatine for blood sugar — Creatine Grade C
- All interventions graded for blood sugar →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
How long does NMN take to work for blood sugar?
Trials of NMN for blood sugar typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of NMN for blood sugar?
Studied doses for NMN in blood sugar trials cluster around 250-2000 mg/day, 14 days to 12 weeks in the reviewed trials. See the dose block for the specific range and how it varies by form.
Does NMN work for blood sugar if I'm not deficient?
The effect concentrates in middle-age/older adults, mainly non-diabetic. If your baseline is normal, expect a smaller effect than the trial averages.
NMN or the next-best alternative for blood sugar?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- Review of 8 human RCTs (342 mainly non-diabetic middle-age/older adults, 14 days to 12 weeks, 250-2000 mg/day): NMN supplementation showed no significant benefit on fasting glucose, fasting insulin, HbA1c, insulin resistance (HOMA-IR), or lipid profile. Short-term NMN supplementation did not meaningfully improve glucose control in this population.
- Substrate's interpretation
- Grade — at low certainty — the direction and size the studies converge on, as our reading of the corpus.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Does NMN help blood sugar?. https://evidencebased.info/interventions/nmn/blood-sugar. Updated 2026-07-16.
BibTeX
@misc{substrate_entionsnmnbloodsugar,
author = {Substrate editorial},
title = {Does NMN help blood sugar?},
year = {2026},
url = {https://evidencebased.info/interventions/nmn/blood-sugar},
note = {evidencebased.info}
}Found something wrong on this page? Report an error →